Myovant Sciences Ltd (MYOV) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Myovant Sciences Ltd   (NYSE: MYOV)


Myovant Sciences Ltd's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Myovant Sciences Ltd's ROI in the third quarter of 2023?
Myovant Sciences Ltd recorded a cumulative net loss of $-184 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -82.26%.

Within the Healthcare sector 938 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 5574.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Investment Change TTM -44.51 % -40.4 % -14.09 % 29.52 % 135 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 158 232 234 270 335
Return On Investment (TTM) -82.26 % -70.8 % -52.98 % -57.36 % -56.65 %
MYOV's Overall Ranking # 5574 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -16.57 % -14.31 % -12.97 % -10.81 % -10.4 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -184 -190 -166 -206 -228

MYOV Company Profile >> Back to MYOV Roi Comparisons >> See Annual MYOV Return On Investment



Return On Investment MYOV's Ranking
Within: No.
Industry # 445
Sector # 939
Overall # 5574

Return On Investment Statistics
High Average Low
-52.98 %
-167.36 %
-418.57 %
(Jun 30 2022)   (Sep 30 2020)







Financial Statements
Myovant Sciences Ltd's III. Quarter Investments $ 158 Millions MYOV's Balance sheet
Myovant Sciences Ltd's III. Quarter Income $ -58 Millions Quarterly MYOV's Income Statement
MYOV's Income by Division See MYOV's Income by Division


MYOV Annual Return On Investment (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Investments in Millions 270 444 20 101 82
Y / Y Investment Growth -39.22 % 2118.32 % -80.2 % 23.54 % -51.02 %
Net Income in Millions -206 -255 -289 -274 -143
Y / Y Net Income Growth - - - - -
Annual Return On Investment -76.38 % -57.5 % -1444.87 % -270.83 % -175.21 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MYOV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MYOV's Competitors
Subscribers only: Roi for Myovant Sciences Ltd's Suppliers
Subscribers only: Return On Investment for MYOV's Customers

Other Ratios
MYOV's Roa MYOV's Inventory Turnover Ratio MYOV's Growth Rates MYOV's Dividend Statistics
MYOV's Profitability Ratios MYOV's Asset Turnover Ratio MYOV's Dividend Growth
MYOV's Roe MYOV's Valuation Ratios MYOV's Financial Strength Ratios MYOV's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-26T07:31:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.